Results 11 to 20 of about 48,363 (248)

Proprotein Convertase Subtilisin Kexin 9 Inhibitors [PDF]

open access: yesCardiology Clinics, 2018
High levels of low-density lipoprotein cholesterol (LDL-C) are directly associated with an increased risk of cardiovascular disease. Reducing LDL-C levels reduces the incidence of cardiovascular events. Several lipid-lowering approaches are available to achieve the LDL-C levels recommended by current guidelines, statins being the first-line therapy ...
A. Pirillo, A. L. Catapano
openaire   +2 more sources

Apolipoprotein F is reduced in humans with steatosis and controls plasma triglyceride‐rich lipoprotein metabolism

open access: yesHepatology, EarlyView., 2022
Hepatic APOF transcript levels correlate inversely with plasma TG and hepatic steatosis in humans. ApoF expression in mice promotes VLDL‐TG production and lipoprotein remnant clearance in mice. Abstract Background NAFLD affects nearly 25% of the global population. Cardiovascular disease (CVD) is the most common cause of death among patients with NAFLD,
Audrey Deprince   +30 more
wiley   +1 more source

Proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors [PDF]

open access: yesCanadian Medical Association Journal, 2019
PCSK9 is a protease that degrades hepatic LDL-C receptors. Evolocumab and alirocumab are fully human monoclonal antibodies administered as subcutaneous injections that inhibit PCSK9, preserving receptor availability to clear circulating LDL-C.[1][1],[2][2] In randomized, placebo-controlled ...
Derek, Leong, Peter E, Wu
openaire   +2 more sources

PCSK5 (Proprotein Convertase Subtilisin/Kexin Type 5) [PDF]

open access: yesAtlas of Genetics and Cytogenetics in Oncology and Haematology, 2015
Review on PCSK5 (Proprotein Convertase Subtilisin/Kexin Type 5), with data on DNA, on the protein encoded, and where the gene is implicated.
Khatib, M, Demoures, B
openaire   +2 more sources

PCSK1 (proprotein convertase subtilisin/kexin type 1) [PDF]

open access: yesAtlas of Genetics and Cytogenetics in Oncology and Haematology, 2018
PCSK1 is a serine protease involved in the proteolytic processing of a variety of protein precursors mainly neuropeptides and prohormones. In 1991, PC1/3; also known as PCSK1, PC1, PC3, and SPC3 was identified at the same time by two laboratories separately. The human and mouse PCSK1 genes are localized on chromosomes 5 and 13, respectively.
Demoures, Béatrice   +2 more
openaire   +2 more sources

A three-player game analysis on industrial environmental pollution control [PDF]

open access: yesE3S Web of Conferences, 2021
The environmental pollution of industrial enterprises has severely restricted the development of economy and society. In the face of serious industrial environmental pollution, this paper constructs a three-player game model including enterprises ...
Hou Kexin
doaj   +1 more source

Suppressor of Cytokine Signaling-3 (SOCS-3) induces Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) expression in hepatic HepG2 cell line [PDF]

open access: yes, 2015
The suppressor of cytokine signaling (SOCS) proteins are negative regulators of the JAK/STAT pathway activated by proinflammatory cytokines, including the tumor necrosis factor (TNF-\u3b1).
Corsini, Alberto   +7 more
core   +2 more sources

Processing of Candida albicans Ece1p Is Critical for Candidalysin Maturation and Fungal Virulence

open access: yesmBio, 2018
Candida albicans is an opportunistic fungal pathogen responsible for superficial and life-threatening infections in humans. During mucosal infection, C. albicans undergoes a morphological transition from yeast to invasive filamentous hyphae that secrete ...
Jonathan P. Richardson   +19 more
doaj   +1 more source

Repetitive DNA is Functional and Encodes Parts of the Non‐Coding RNA Repertoire

open access: yesAdvanced Genetics, 2022
This is a commentary on the article by Eviatar Nevo and Kexin Li entitled “Sympatric Speciation in Mole Rats and Wild Barley and Their Genome Repeatome Evolution: A Commentary”, published recently in Advanced Genetics.
James A. Shapiro
doaj   +1 more source

HIV and Hepatitis C-Coinfected Patients Have Lower Low-Density Lipoprotein Cholesterol Despite Higher Proprotein Convertase Subtilisin Kexin 9 (PCSK9): An Apparent "PCSK9-Lipid Paradox". [PDF]

open access: yes, 2016
BackgroundProprotein convertase subtilisin kexin 9 (PCSK9) inhibitors reduce low-density lipoprotein cholesterol (LDL-C) and improve outcomes in the general population.
Deeks, Steven   +10 more
core   +1 more source

Home - About - Disclaimer - Privacy